Medical network - on September 6, said zhang wei, secretary general of the China pharmacopoeia committee 5, will be introduced in 2020, the 11th edition of the "pharmacopoeia of the People's Republic of China is expected to number about 6400 contains variety, though a variety of 800, the revised 1400 varieties.
Zhang wei in the national pharmacopoeia committee press conference pointed out that, after a calendar version pharmacopoeia contains varieties increased significantly, current edition pharmacopoeia has reached a complete coverage of basic drugs, health care drugs, can adapt to the needs of clinical medicine. Edition pharmacopoeia 2020 varieties contains moderate growth, one is to consider the adjustment of the directory, the second is the tone of the contains the drugs work amount, to pay attention to the inherent quality of drug promotion transformation, namely no longer blindly pursue quantity, but more emphasis on quality.
It is understood that the new edition of pharmacopoeia will further improve the standard system and strengthen the concept of whole-process management of drug quality. Zhang wei to point out that, the new pharmacopoeia perfect and rich connotation of drug standards, strengthen the process control, controlled by drug terminal to the production process and source control, realize the drug quality control standard system of the life cycle. Create horizontal Chinese medicine, chemical medicine, biological products, active pharmaceutical ingredients, pharmaceutical excipients, medicine packaging material quality control, technical requirements and standards, longitudinal covering pharmacopoeia notice, the general principles of the preparation, general, the general principles of the test methods and guiding principles, and gradually strengthen and perfect the related to drug research and development, production, distribution and use of general technical requirements and guidelines of drug standards system.
Next, the national pharmacopoeia commission will establish a national drug standard elimination mechanism. Zhang wei, will "have to have a" standard, to an approval number has been cancelled, long-term don't production, quality control, dosage form is not reasonable, the stability is not high pharmaceutical standards of "subtraction", so as to realize standard, thoroughly solve longstanding problems in pharmaceutical standards.
The 2015 edition of the pharmacopoeia of the People's Republic of China is the 10th edition of the pharmacopoeia since the founding of new China. The total number of drugs in China's pharmacopoeia reached 5,608, covering basic drugs, medical insurance catalog varieties and clinical drugs.
|
